Skip to content
Research Article Open access CC BY 3.0

Adapting Cervical Dysplasia Screening, Treatment and Prevention Approaches to Low Resource Settings

Elizabeth K. Vonder Haar, Kei Kawana, Danny J. Schust

International STD Research & Reviews · pp. 39–48 · Published 27 Sep 2013

10.9734/ISRR/2013/5781

Abstract

Cervical cancer is a common disorder worldwide. Screening and treatment paradigms in highly developed countries have dramatically decreased disease prevalence and the implementation of preventive vaccination against high risk human papillomavirus (HPV) subtypes should decrease prevalence even further. Promising advances are also being made toward the development of a therapeutic vaccine for cervical neoplasia. Under-resourced countries suffer from an inability to implement many of the approaches to prevention and diagnosis that have proved successful in countries with adequate resources. Several protocols are presently being developed that are low cost and require minimal training and infrastructure that may allow low-resource areas to begin to improve the early diagnosis of low and moderate grade cervical neoplasia. These protocols should support efforts at early treatment to prevent progression to cancer. Simultaneous expansion of prophylactic and possibly therapeutic vaccine availability is essential in the worldwide fight against this prevalent but largely preventable disease.

Cervical neoplasia CIN screening vaccine human papillomavirus HPV

References (26)

  1. 1 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [DOI]
  2. 2 Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women [DOI]
  3. 3 American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer [DOI]
  4. 4 HPV Screening for Cervical Cancer in Rural India [DOI]
  5. 5 Overview of the European and North American studies on HPV testing in primary cervical cancer screening [DOI]
  6. 6 Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries [DOI]
  7. 7 Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women [DOI]
  8. 8 Pathology and epidemiology of HPV infection in females [DOI]
  9. 9 HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study [DOI]
  10. 10 Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis [DOI]
  11. 11 Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial [DOI]
  12. 12 Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis [DOI]
  13. 13 Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
  14. 14 Human papillomavirus and cervical cancer [DOI]
  15. 15 Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa [DOI]
  16. 16 Evidence-based, alternative cervical cancer screening approaches in low-resource settings. [DOI]
  17. 17 Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings [DOI]
  18. 18 Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7 [DOI]
  19. 19 A Population-Based Study of Visual Inspection With Acetic Acid (VIA) for Cervical Screening in Rural Nigeria [DOI]
  20. 20 Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach [DOI]
  21. 21 Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear [DOI]
  22. 22 Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country [DOI]
  23. 23 "See and treat" approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy.
  24. 24 Leucoplakia, leucokeratosis, and carcinoma of the cervix [DOI]
  25. 25 Evaluation of visual inspection as the primary screening method in a four-year cervical (pre-) cancer screening program in rural China [DOI]
  26. 26 Evaluation of Cervical Biopsies Guided by Visual Inspection With Acetic Acid [DOI]

Cited by 4

Women’s Select Health Issues in Underserved Populations

Luz M. Fernandez, Jonathan A. Becker · Primary Care: Clinics in Office Practice · 2017

Women’s Select Health Issues in Underserved Populations

Luz M. Fernandez, Jonathan A. Becker · Physician Assistant Clinics · 2019

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

31

Page views

0

PDF downloads

4

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.